Insulin-like growth factor I in relation to prostate cancer and benign prostatic hyperplasia - reply to the letter from Cohen, Peehl and Rosenfeld
1998
Insulin-like Growth Factor I and Prostate Cancer
Sample size: 103
publication
Evidence: moderate
Author Information
Author(s): CS Mantzoros, LB Signorello, D Trichopoulos
Primary Institution: Harvard School of Public Health
Hypothesis
Is there a relationship between insulin-like growth factor I (IGF-1) and prostate cancer?
Conclusion
The study found no relationship between IGF-1 and benign prostatic hyperplasia after adjusting for confounding variables.
Supporting Evidence
- The authors argue that the lack of statistical significance in previous studies may be due to limited sample sizes.
- The study referenced by Cohen et al. had only 51 cases and 52 controls, which is relatively small.
- Another study mentioned had only seven controls, indicating a potential issue with statistical power.
Takeaway
The study looked at a hormone called IGF-1 and found it doesn't cause prostate problems, even though some other studies suggested it might.
Limitations
The study's findings may be limited by the statistical power due to sample size.
Statistical Information
P-Value
0.06
Statistical Significance
p=0.06
Want to read the original?
Access the complete publication on the publisher's website